Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

13.3K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K
Ecological Succession02:17

Ecological Succession

21.4K
Ecological succession is influenced by the processes of facilitation, inhibition, and toleration. Facilitation occurs when early successional species create more favorable ecological conditions for subsequent species, such as enhanced nutrient, water, or light availability. In contrast, inhibition happens when early successional species create unfavorable ecological conditions for potential successive species, such as limiting resource availability. In some cases, later successional species...
21.4K
Factors Affecting Activity Coefficient01:17

Factors Affecting Activity Coefficient

1.5K
The extended Debye-Hückel equation indicates that the activity coefficient of an ion in an aqueous solution at 25°C depends on three partially interdependent properties: the ionic strength of the solution, the charge of the ion, and the ion size. 
The activity coefficient value for an ion is close to one when the solution has almost zero ionic strength, i.e., when the solution shows close to ideal behavior. As the ionic strength of the solution increases from 0 to 0.1 mol/L, a...
1.5K
Bleeding in Fresh Concrete01:22

Bleeding in Fresh Concrete

548
Bleeding in fresh concrete occurs when water from the mix rises to the surface. This happens because the mix's solid components fail to retain all the water as they settle, leading to separation where water collects at the top. The severity of bleeding can be measured by assessing the total settlement or by noting the decrease in height per unit height of concrete.
Bleeding can cause several issues in the concrete structure. Sometimes, the rising water gets trapped beneath large aggregate...
548
Overview of Transposition and Recombination02:13

Overview of Transposition and Recombination

19.0K
Transposons make up a significant part of genomes of various organisms. Therefore, it is believed that transposition played a major evolutionary role in speciation by changing genome sizes and modifying gene expression patterns. For example, in bacteria, transposition can lead to conferring antibiotic resistance. Movement of transposable elements within the genetic pool of pathogenic bacteria can aid in transfer of antibiotic-resistant genetic elements. In eukaryotes, transposons can carry out...
19.0K
Dysrhythmias VII: Nursing Management of Dysrhythmias01:25

Dysrhythmias VII: Nursing Management of Dysrhythmias

376
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
376

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intra-Arterial thrombolysis after SUCCESSful angiographic recanalization in acute large-vessel occlusion stroke of the anterior circulation (IA-SUCCESS): a multicentre, randomised, clinical trial protocol.

European stroke journal·2026
Same author

Combined stent retriever and contact aspiration improves first-line recanalisation but not clinical outcomes: a pooled analysis of the ASTER, ASTER2, and VECTOR trials.

European stroke journal·2026
Same author

Impact of Neutrophil Extracellular Traps on Clinical Outcome after Subarachnoid Hemorrhage: A Translational Narrative Review.

Translational stroke research·2026
Same author

Cardiac and extracardiac outcomes after heart transplantation in laminopathies.

Heart (British Cardiac Society)·2026
Same author

Clinical impact of guideline-directed medical therapy in patients with left ventricular assist device: an international multicentre study.

ESC heart failure·2026
Same author

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026

Related Experiment Video

Updated: Jan 22, 2026

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

9.4K

Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report.

Anne Godier1,2,3, Mélanie Dupont1, Jean-Philippe Desilles4,5,6

  • 1Service d'Anesthésie-Réanimation, Fondation Adolphe de Rothschild, Paris, France.

TH Open : Companion Journal to Thrombosis and Haemostasis
|June 29, 2019
PubMed
Summary

Recombinant activated factor VII (rFVIIa) may help manage bleeding from ticagrelor, an antiplatelet drug. This case study shows rFVIIa improved clotting, but careful risk assessment is crucial due to potential side effects like pulmonary embolism.

Keywords:
antithromboticplatelet transfusionrecombinant activated factor VIIreversalticagrelor

More Related Videos

Rapid Synthesis and Screening of Chemically Activated Transcription Factors with GFP-based Reporters
09:22

Rapid Synthesis and Screening of Chemically Activated Transcription Factors with GFP-based Reporters

Published on: November 26, 2013

15.0K
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.4K

Related Experiment Videos

Last Updated: Jan 22, 2026

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins
11:40

Simplified Reverse Genetics Method to Recover Recombinant Rotaviruses Expressing Reporter Proteins

Published on: April 17, 2020

9.4K
Rapid Synthesis and Screening of Chemically Activated Transcription Factors with GFP-based Reporters
09:22

Rapid Synthesis and Screening of Chemically Activated Transcription Factors with GFP-based Reporters

Published on: November 26, 2013

15.0K
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

7.4K

Area of Science:

  • Pharmacology
  • Hematology
  • Neurosurgery

Background:

  • Ticagrelor is an antiplatelet medication associated with challenging bleeding complications, particularly in neurosurgical patients.
  • Current management strategies, including platelet transfusions, are often ineffective, and no specific antidote exists.
  • Recombinant activated factor VII (rFVIIa) is a procoagulant agent used to control bleeding in specific situations.

Observation:

  • A patient on ticagrelor requiring emergent neurosurgery for an intracranial hematoma received platelet transfusions and rFVIIa.
  • Laboratory tests indicated that platelet transfusion did not reverse ticagrelor's antiplatelet effect.
  • rFVIIa administration was associated with improved hemostasis, evidenced by a shortened thromboelastometric clotting time.

Findings:

  • The use of rFVIIa successfully improved hemostasis in a patient experiencing ticagrelor-induced platelet inhibition.
  • The neurosurgery proceeded without intraoperative bleeding complications.
  • Despite successful hemostasis, the patient developed a postoperative pulmonary embolism, highlighting potential risks.

Implications:

  • rFVIIa presents a potential therapeutic option for managing ticagrelor-associated bleeding, especially in critical settings like neurosurgery.
  • The use of rFVIIa requires a thorough evaluation of the benefit-risk profile due to the possibility of thrombotic events.
  • Further research is needed to establish the efficacy and safety of rFVIIa as an antidote for ticagrelor-induced bleeding.